{
    "id": "bowtie_digoxin_renal_v2026_60",
    "type": "bowtie",
    "stem": "An 82-year-old client with chronic heart failure (CHF) and stage 4 Chronic Kidney Disease (CKD) reports feeling 'unusually nauseated' and seeing 'yellow circles around the lights.' Based on the documentation in the Cardiorenal & Pharmacokinetic Log tab, complete the bowtie by selecting the most likely condition, the two actions the nurse should take, and the two parameters the nurse should monitor.",
    "itemContext": {
        "tabs": [
            {
                "id": "sbar",
                "title": "SBAR",
                "content": "<b>Situation:</b> Suspected drug toxicity in a multi-morbid elderly patient. <br><b>Background:</b> Taking Digoxin 0.125mg and Spironolactone 25mg daily. <br><b>Assessment:</b> Heart rate is 52 bpm. Client appears pale and lethargic. <br><b>Recommendation:</b> Immediate evaluate of cardiorenal stability."
            },
            {
                "id": "cardiorenal",
                "title": "Cardiorenal & Pharmacokinetic Log",
                "content": "<table><thead><tr><th>Assessment</th><th>Result</th><th>Interpretation</th></tr></thead><tbody><tr><td>Serum Digoxin</td><td>2.4 ng/mL</td><td>Toxic (> 2.0)</td></tr><tr><td>Serum Potassium (K+)</td><td>5.8 mEq/L (High)</td><td>Hyperkalemia (Spironolactone)</td></tr><tr><td>Estimated GFR</td><td>22 mL/min (Low)</td><td>Critical filtration failure</td></tr><tr><td>Creatinine</td><td>3.2 mg/dL</td><td>Rising kidney injury</td></tr></tbody></table>"
            },
            {
                "id": "vitals",
                "title": "Vital Signs",
                "content": "BP 92/58, HR 52 (Reg), RR 16, T 97.2Â°F. Client is seeing 'halos.'"
            }
        ]
    },
    "bowtieData": {
        "conditionOptions": [
            {
                "id": "c1",
                "text": "Stable CHF with Electrolyte Variance"
            },
            {
                "id": "c2",
                "text": "Renal Failure-Induced Digoxin Toxicity & Hyperkalemia"
            },
            {
                "id": "c3",
                "text": "Incipient Septic Shock (Geriatric)"
            }
        ],
        "actionOptions": [
            {
                "id": "a1",
                "text": "Hold both the Digoxin and the Spironolactone doses"
            },
            {
                "id": "a2",
                "text": "Notify the provider of the toxic digoxin level and hyperkalemia"
            },
            {
                "id": "a3",
                "text": "Administer IV Potassium Chloride (KCl) to resolve the nausea"
            },
            {
                "id": "a4",
                "text": "Instruct the client to significantly increase intake of bananas and leafy greens"
            }
        ],
        "parameterOptions": [
            {
                "id": "p1",
                "text": "Continuous EKG for rhythm changes and peaked T-waves"
            },
            {
                "id": "p2",
                "text": "Serum Digoxin, Potassium, and GFR/Creatinine levels"
            },
            {
                "id": "p3",
                "text": "Daily measurement of fasting serum glucose"
            },
            {
                "id": "p4",
                "text": "Presence of a positive Babinski sign"
            }
        ]
    },
    "correctAnswers": {
        "condition": "c2",
        "actions": [
            "a1",
            "a2"
        ],
        "parameters": [
            "p1",
            "p2"
        ]
    },
    "pedagogy": {
        "bloomLevel": "analyze",
        "cjmmStep": "takeAction",
        "nclexCategory": "Pharmacological and Parenteral Therapies",
    "difficulty: 4,"topicTags": [
            "Digoxin Toxicity",
            "Hyperkalemia",
            "Renal Failure"
        ]
    },
    "rationale": {
        "correct": "This is a complex toxic state (c2). The client's renal failure (GFR 22) has led to the accumulation of Digoxin (2.4 ng/mL), while her use of a potassium-sparing diuretic (Spironolactone) in the setting of renal failure has caused hyperkalemia (5.8). This combination is high-risk for lethal arrhythmias. The nurse must hold both drugs (a1) and notify the provider (a2). Monitoring EKG for both digoxin effects (bradycardia) and hyperkalemia effects (peaked T-waves) (p1) plus lab trends (p2) is mandatory.",
        "clinicalPearls": [
            "Digoxin is 100% renally cleared. If the kidneys fail, the Digoxin MUST be dose-adjusted or stopped.",
            "Visual halos (scotoma) are the classic 'color' change associated with digitalis poisoning.",
            "Spironolactone + Renal Failure = Hyperkalemia. Hyperkalemia + Digoxin = Dangerous Electrical Dysfunction."
        ],
        "questionTrap": {
            "trap": "Thinking Hyperkalemia PROTECTS from Digoxin toxicity.",
            "howToOvercome": "Hypokalemia makes the toxicity MORE LIKELY, but Hyperkalemia + Digoxin still causes rhythm failure and indicates a severe metabolic crash."
        },
        "mnemonic": {
            "title": "Digitalis Danger",
            "expansion": "D-Decreased HR. I-Indigestion (N/V). G-Glows (Halos). I-Increased K+ (In renal failure)."
        }
    },
    "scoring": {
        "method": "polytomous",
        "maxPoints": 5
    },
    "sentinelStatus": "healed_v2026_v9"
}